TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma.

Andrew B Lassman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.